Human CD8+ T cell memory generation in Puumala hantavirus infection occurs after the acute phase and is associated with boosting of EBV-specific CD8+ memory T cells

Journal of Immunology

Volumn 179, Issue 3, 2007, Pages 1988-1995

  Tuuminen, Tamara ^a,e   Kekäläinen, Eliisa ^a   Mäkelä, Satu ^d   Ala Houhala, Ilpo ^d   Ennis, Francis A ^b   Hedman, Klaus ^a,e   Mustonen, Jukka ^c,d   Vaheri, Antti ^a   Arstila, T Petteri ^a,e  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d TAMPERE UNIVERSITY HOSPITAL   (Finland)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 15 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR ALPHA; MEMBRANE PROTEIN; EPITOPE; INTERLEUKIN 7 RECEPTOR; INTERLEUKIN 7 RECEPTOR, ALPHA CHAIN; INTERLEUKIN-7 RECEPTOR, ALPHA CHAIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CD8+ T LYMPHOCYTE; CELL POPULATION; CELL SPECIFICITY; CLINICAL ARTICLE; CONTROLLED STUDY; CRUSH SYNDROME; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; FEMALE; FOLLOW UP; HANTAVIRUS; HEMORRHAGIC FEVER; HUMAN; MALE; MEMORY T LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUUMALA VIRUS; VIRUS INFECTION; VIRUS REACTIVATION; ACUTE DISEASE; BIOSYNTHESIS; CYTOLOGY; IMMUNIZATION; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; KINETICS; LYMPHOCYTE ACTIVATION; METABOLISM; MIDDLE AGED; VIROLOGY; VIRUS ACTIVATION;

ACUTE DISEASE; ADULT; AGED; CD8-POSITIVE T-LYMPHOCYTES; EPITOPES, T-LYMPHOCYTE; FEMALE; HANTAVIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOLOGIC MEMORY; INTERLEUKIN-15 RECEPTOR ALPHA SUBUNIT; KINETICS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PUUMALA VIRUS; RECEPTORS, INTERLEUKIN-7; VIRUS ACTIVATION;

EID: 34548627666     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.3.1988     Document Type: Article

References (48)

1. Crotty, S., and R. Ahmed. 2004. Immunological memory in humans. Semin. Immunol. 16: 197-203.
2. Welsh, R. M., L. K. Selin, and E. Szomolanyi-Tsuda. 2004. Immunological memory to viral infections. Annu. Rev. Immunol. 22: 711-743.
3. Kaech, S. M., S. Hemby, E. Kersh, and R. Ahmed. 2002. Molecular and functional profiling of memory CD8 T cell differentiation. Cell 111: 837-851.
4. Sallusto, F., D. Lenig, R. Forster, M. Lipp, and A. Lanzavecchia. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401: 708-712.
5. Appay, V., and S. L. Rowland-Jones. 2004. Lessons from the study of T-cell differentiation in persistent human virus infection. Semin. Immunol. 16: 205-212.
6. Robinson, H. L., and R. R. Amara. 2005. T cell vaccines for microbial infections. Nat. Med. 11: S25-S32.
7. Kanerva, M., J. Mustonen, and A. Vaheri. 1998. Pathogenesis of puumala and other hantavirus infections. Rev. Med. Virol. 8: 67-86.
8. Vapalahti, O., J. Mustonen, A. Lundkvist, H. Henttonen, A. Plyusnin, and A. Vaheri. 2003. Hantavirus infections in Europe. Lancet Infect. Dis. 3: 653-661.
9. Terajima, M., O. Vapalahti, H. L. Van Epps, A. Vaheri, and F. Ennis. 2004. Immune responses to Puumala virus infection and the pathogenesis of nephropathia epidemica. Microbes Infect. 6: 238-245.
10. Plyusnin, A., J. Horling, M. Kanerva, J. Mustonen, Y. Cheng, J. Partanen, O. Vapalahti, S. K. Kukkonen, J. Niemimaa, H. Henttonen, et al. 1997. Puumala hantavirus genome in patients with nephropathia epidemica: correlation of PCR positivity with HLA haplotype and link to viral sequences in local rodents. J. Clin. Microbiol. 35: 1090-1096.
11. Plyusnin, A., J. Mustonen, K. Asikainen, A. Plyusnina, J. Niemimaa, H. Henttonen, and A. Vaheri. 1999. Analysis of Puumala hantavirus genome in patients with nephropathia epidemica and rodent carriers from the sites of infection. J. Med. Virol. 59: 397-405.
12. Settergren, B., C. Ahlm, P. Juto, and B. Niklasson. 1991. Specific Puumala IgG virus half a century after haemorrhagic fever with renal syndrome. Lancet 338: 66.
13. Van Epps, H. L., M. Terajima, J. Mustonen, T. P. Arstila, E. A. Corey, A. Vaheri, and F. A. Ennis. 2002. Long-lived memory T lymphocyte responses after hantavirus infection. J. Exp. Med. 196: 579-588.
14. Mustonen, J., J. Partanen, M. Kanerva, K. Pietila, O. Vapalahti, A. Pasternack, and A. Vaheri. 1996. Genetic susceptibility to severe course of nephropathia epidemica caused by Puumala hantavirus. Kidney Int. 49: 217-221.
15. Mäkela, S., J. Mustonen, I. Ala-Houhala, M. Hurme, J. Partanen, O. Vapalahti, A. Vaheri, and A. Pasternack. 2002. Human leukocyte antigen-B8-DR3 is a more important risk factor for severe Puumala hantavirus infection than the tumor necrosis factor-α(-308) G/A polymorphism. J. Infect. Dis. 186: 843-846.
16. + T cells in the severity of a fulminant zoonotic viral hemorrhagic fever, hantavirus pulmonary syndrome. J. Immunol. 172: 3297-3304.
17. Korhonen, M. H., J. Brunstein, H. Haario, A. Katnikov, R. Rescaldani, and K. Hedman. 1999. A new method with general diagnostic utility for the calculation of immunoglobulin G avidity. Clin. Diagn. Lab. Immunol. 6: 725-728.
18. Aalto, S. M., E. Juvonen, J. Tarkkanen, L. Volin, T. Ruutu, P. S. Mattila, H. Piiparinen, S. Knuutila, and K. Hedman. 2003. Lymphoproliferative disease after allogeneic stem cell transplantation: preemptive diagnosis by quantification of Epstein-Barr virus DNA in serum. J. Clin. Virol. 28: 275-283.
19. Welsh, R. M. 2001. Assessing CD8 T cell number and dysfunction in the presence of antigen. J. Exp. Med. 193: F19-F22.
20. Mathew, A., I. Kurane, S. Green, D. W. Vaughn, S. Kalayanarooj, S. Suntayakorn, F. A. Ennis, and A. L. Rothman. 1999. Impaired T cell proliferation in acute dengue infection. J. Immunol. 162: 5609-5615.
21. Mathew, A., F. A. Ennis, and A. L. Rothman. 2000. Transient decreases in human T cell proliferative responses following vaccinia immunization. Clin. Immunol. 96: 100-107.
22. Schluns, K. S., and L. Lefrancois. 2003. Cytokine control of memory T-cell development and survival. Nat. Rev. Immunol. 3: 269-279.
23. Kaech, S. M., J. T. Tan, E. J. Wherry, B. T. Konieczny, C. D. Surh, and R. Ahmed. 2003. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat. Immunol. 4: 1191-1198.
24. Schluns, K. S., K. Williams, A. Ma, X. X. Zheng, and L. Lefrançois. 2002. Cutting edge: requirement for IL-15 in the generation of primary and memory antigen-specific CD8 T cells. J. Immunol. 168: 4827-4831.
25. Linderholm, M., C. Ahlm, B. Settergren, A. Waage, and A. Tarnvik. 1996. Elevated plasma levels of tumor necrosis factor (TNF)-α, soluble TNF receptors, interleukin (IL)-6, and IL-10 in patients with hemorrhagic fever with renal syndrome. J. Infect. Dis. 173: 38-43.
26. Schrum, A. G., L. A. Turka, and E. Palmer. 2003. Surface T-cell antigen receptor expression and availability for long-term antigenic signaling. Immunol. Rev. 196: 7-24.
27. Zinkernagel, R. M. 2002. On differences between immunity and immunological memory. Curr. Opin. Immunol. 14: 523-536.
28. Murali-Krishna, K., L. L. Lau, S. Sambhara, F. Lemonnier, J. Altman, and R. Ahmed. 1999. Persistence of memory CD8 T cells in MHC class I-deficient mice. Science 286: 1377-1381.
29. Kassiotis, G., S. Garcia, E. Simpson, and B. Stockinger. 2002. Impairment of immunological memory in the absence of MHC despite survival of memory T cells. Nat. Immunol. 3: 244-250.
30. Demkowicz, W. E. J., R. A. Littaua, J. Wang, and F. A. Ennis. 1996. Human cytotoxic T-cell memory: long-lived responses to vaccinia virus. J. Virol. 70: 2627-2631.
31. Hammarlund, E., M. W. Lewis, S. G. Hansen, L. I. Strelow, J. A. Nelson, G. J. Sexton, J. M. Hanifin, and M. K. Slifka. 2003. Duration of antiviral immunity after smallpox vaccination. Nat. Med. 9: 1131-1137.
32. + cytotoxic T-cell responses and long-term T-cell memory in individuals vaccinated against polio. J. Virol. 79: 5988-5995.
33. Busch, D. H., and E. G. Pamer. 1999. T cell affinity maturation by selective expansion during infection. J. Exp. Med. 15: 701-710.
34. + T cell populations specific for persistent DNA viruses. J. Exp. Med. 202: 1349-1361.
35. Welsh, R. M., and L. K. Selin. 2002. No one is naive: the significance of heterologous T-cell immunity. Nat. Rev. Immunol. 2: 417-426.
36. Rickinson, A. B., and E. Kieff. 2001. Epstein-Barr virus. In Field's Virology. D. M. Knipe, and P. M. Howley, eds. Lippincott, Williams, and Wilkins, Philadelphia, PA, pp. 2575-2627.
37. Gerber, P., S. Lucas, M. Nonoyama, E. Perlin, and L. I. Goldstein. 1972. Oral excretion of Epstein-Barr virus by healthy subjects and patients with infectious mononucleosis. Lancet 2: 988-989.
38. Niesters, H. G., J. van Esser, E. Fries, K. C. Wolthers, J. Cornelissen, and O. A.D. 2000. Development of a real-time quantitative assay for detection of Epstein-Barr virus. J. Clin. Microbiol. 38: 712-715.
39. Aalto, S. M., K. Linnavuori, H. Peltola, E. Vuori, B. Weissbrich, J. Schubert, L. Hedman, and K. Hedman. 1998. Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection. J. Med. Virol. 56: 186-191.
40. Jääskeläinen, A., H. Piiparinen, M. Lappalainen, M. Koskiniemi, and A. Vaheri. 2006. Multiplex-PCR and oligonucleotide microarray for detection of eight different herpesviruses from clinical specimens. J. Clin. Virol. 37: 83-90.
41. Scheinberg, P., S. H. Fischer, L. Li, O. Nunez, C. O. Wu, E. M. Sloand, J. I. Cohen, N. S. Young, and A. J. Barrett. 2007. Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia. Blood 109: 3219-3224.
42. + T cells specific for EBV, cytomegalovirus, and influenza virus are activated during primary HIV infection. J. Immunol. 173: 2410-2418.
43. Amer, A. O., and M. S. Swanson. 2002. A phagosome of one's own: a microbial guide to life in the macrophage. Curr. Opin. Microbiol. 5: 56-61.
44. Ebell, M. H. 2004. Epstein-Barr virus infectious mononucleosis. Am. Fam. Physician 70: 1279-1287.
45. Urbani, S., B. Amadei, P. Fisicaro, M. Pilli, G. Missale, A. Bertoletti, and C. Ferrari. 2005. Heterologous T cell immunity in severe hepatitis C virus infection. J. Exp. Med. 201: 675-680.
46. + T cells dominate the memory compartments of exposed subjects. J. Exp. Med. 202: 673-685.
47. Effros, R. B., Z. Cai, and P. J. Linton. 2003. CD8 T cells and aging. Crit. Rev. Immunol. 23: 45-64.
48. Hadrup, S. R., J. Strindhall, T. Kollgaard, T. Seremet, B. Johansson, G. Pawelec, P. thor Straten, and A. Wikby. 2006. Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly. J. Immunol. 176: 2645-2653.